At the news
? NEUTRALIMPACT 3/10 144 filed Apr 8, 2026 at 16:21 ET
Jennifer Jarrett, an officer of Arcus Biosciences, filed a Form 144 to notify intent to sell 70,000 shares of common stock, valued at approximately $1.58 million based on current market prices. The shares were acquired via stock option exercise and the sale is planned on the NYSE.
- Reporting person: Jennifer Jarrett, Officer
- Number of shares intended for sale: 70,000
- Approximate value of shares: $1,579,592 (based on $22.56/share)
- Shares acquired via: Stock option exercise
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access